Analyzing Clinical Research Participation of Patients With Spinal Cord Injury
A Review of Clinical Trial Experiences and Trends From Spinal Cord Injury Patients
1 other identifier
observational
500
0 countries
N/A
Brief Summary
The percentages of participants in clinical studies haven't always been perfectly representative of a particular group. This research examines the variables that affect a patient's choice to enroll in, discontinue participation in, or resume participation in a clinical trial for spinal cord injury. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future spinal cord injury research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 14, 2023
CompletedFirst Posted
Study publicly available on registry
April 26, 2023
CompletedStudy Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedApril 26, 2023
April 1, 2023
1 year
April 14, 2023
April 14, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Rate of patients who decide to enroll in a spinal cord injury clinical study.
3 months
Number of spinal cord injury study participants who remain in clinical trial until completion.
12 months
Eligibility Criteria
Patients who are actively considering involvement in an observational spinal cord injury clinical trial, but have not yet completed enrollment and registration.
You may qualify if:
- Aged ≥ 18 years old
- Ability to understand and the willingness to sign a written informed consent document.
- Diagnosis of spinal cord injury
You may not qualify if:
- Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
- Has a serious medical or psychiatric illness likely to interfere with participation in this clinical study.
- Inability to provide written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Duan R, Qu M, Yuan Y, Lin M, Liu T, Huang W, Gao J, Zhang M, Yu X. Clinical Benefit of Rehabilitation Training in Spinal Cord Injury: A Systematic Review and Meta-Analysis. Spine (Phila Pa 1976). 2021 Mar 15;46(6):E398-E410. doi: 10.1097/BRS.0000000000003789.
PMID: 33620185BACKGROUNDYamazaki K, Kawabori M, Seki T, Houkin K. Clinical Trials of Stem Cell Treatment for Spinal Cord Injury. Int J Mol Sci. 2020 Jun 2;21(11):3994. doi: 10.3390/ijms21113994.
PMID: 32498423BACKGROUNDKim YH, Ha KY, Kim SI. Spinal Cord Injury and Related Clinical Trials. Clin Orthop Surg. 2017 Mar;9(1):1-9. doi: 10.4055/cios.2017.9.1.1. Epub 2017 Feb 13.
PMID: 28261421BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Michael B Gill
Power Life Sciences Inc.
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 14, 2023
First Posted
April 26, 2023
Study Start
May 1, 2024
Primary Completion
May 1, 2025
Study Completion
May 1, 2026
Last Updated
April 26, 2023
Record last verified: 2023-04